RE1-silencing transcription factor (REST) is a master transcriptional repressor that regulates neuronal gene expression and development. This zinc finger transcription factor binds to RE1 silencing elements in target gene promoters, recruiting chromatin-modifying complexes to silence neuronal genes in non-neuronal cells. REST maintains the balance between neuronal and non-neuronal cell identity, and its dysregulation has been linked to various neurological disorders, cancer, and aging processes.
The Human RE1-silencing transcription factor (REST) ELISA kit (CSB-EL019571HU) provides quantitative measurement of REST in human samples. This sandwich ELISA works with serum, plasma, tissue homogenates, and cell lysates with a detection range of 31.25 pg/mL to 2000 pg/mL and sensitivity of 7.81 pg/mL. The assay requires 50-100 μL sample volume, operates at 450 nm detection wavelength, and can be completed within 1-5 hours.
Application Examples
Note: The following application examples are drawn from a selection of publications citing this product. For additional applications, please refer to the full list of references in the "Citations" section.
This ELISA kit has been applied in neurological research to quantify RE1-silencing transcription factor levels in plasma samples and neuronal-derived exosomes. Applications include biomarker studies examining extracellular vesicle cargo proteins and plasma protein quantification in clinical research contexts.
• Exosome research: Quantification of RE1-silencing transcription factor in neuronal-derived exosomes isolated from plasma, supporting studies of extracellular vesicle cargo proteins and their potential as biomarkers
• Plasma biomarker studies: Direct measurement of RE1-silencing transcription factor levels in plasma samples with specialized sample pretreatment protocols to release protein from extracellular vesicles
• Clinical research: Application in controlled studies comparing different cohorts, with blinded analysis protocols to evaluate protein levels across various clinical conditions and intervention groups
• Neurological research: Integration with panels of other neurological markers to profile protein expression patterns in both plasma and exosome fractions